Skip to main contentSkip to navigation
Sirius Investors
StatSure Diagnostic Systems, Inc.

StatSure Diagnostic Systems, Inc.

SSUR
OTCHealthcare

StatSure Diagnostic Systems, Inc. (SSUR) Investment Research Dashboard

About StatSure Diagnostic Systems, Inc. (SSUR) stock analysis

Get live SSUR stock price $0.00, comprehensive StatSure Diagnostic Systems, Inc. stock analysis, charts, news, sentiment, sector analysis, and expert forecast. Real-time SSUR stock data and investment insights.

0.00
99.60%Today
Market Cap
107.06K
Volume
1
52W High
0.00
52W Low
0.00

Loading chart data...

Investment Score

TTM (current)
Unavailable

A systematic tri-factor framework (valuation, quality, momentum) using trailing twelve-month fundamentals and current price momentum—aligned with the full investment score dashboard.

Score unavailable for this asset.

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

StatSure Diagnostic Systems, Inc. specializes in the creation, production, and distribution of swift in-vitro diagnostic tests. These assays are utilized for identifying infectious diseases and a range of other health concerns, with their availabilit...

Company Information

CEO
Moshe Bodner
Sector
Healthcare
Industry
Medical - Devices
Employees
4

Contact Information

Address
1222 Avenue M
Country
US

Investment Analysis & Business Insights

Healthcare
Medical - Devices

Investment Highlights

Strong presence in the Healthcare sector with established market position

Lower volatility stock (Beta: -1.42) may provide portfolio stability

Important Investment Considerations

  • All investments carry risk, including potential loss of principal for StatSure Diagnostic Systems, Inc. shareholders
  • Market volatility can significantly impact stock price, especially for smaller companies
  • Sector-specific risks in Healthcare may affect company performance
  • Past performance does not guarantee future results for StatSure Diagnostic Systems, Inc.
  • Investors should consider how StatSure Diagnostic Systems, Inc. fits within their overall portfolio allocation

Market Cap

107.06K

0

Beta

-1.42

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.

Healthcare (1D)

76/100 ⭐⭐⭐⭐⭐

Overall
+0.7%
NYSE
+0.6%
NASDAQ
+0.7%
Sector1D1W1MP/EScore
Financial Services+2.2%+3.1%+4.3%19.3
98/100⭐⭐⭐⭐⭐
Communication Services+1.4%+2.9%+4.3%22.2
88/100⭐⭐⭐⭐⭐
Healthcare+0.7%+1.3%+1.6%24.1
76/100⭐⭐⭐⭐⭐
Consumer Defensive-0.2%+1.7%+1.2%29.7
61/100⭐⭐⭐⭐
Basic Materials+0.4%+1.1%-0.2%25.2
58/100⭐⭐⭐⭐
Real Estate-0.5%+0.0%-2.5%29.2
41/100⭐⭐⭐
Energy-2.1%-3.7%-4.1%19.1
39/100⭐⭐
Utilities-1.0%+0.0%-4.4%26.8
35/100⭐⭐
Industrials+0.6%+0.4%-9.9%30.1
21/100
Consumer Cyclical+0.5%-0.9%-5.6%43.0
18/100
Technology+0.6%-1.6%-7.2%40.7
15/100

Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-07-29.